Gree Real Estate Co., Ltd. (SHSE:600185) said unit scraps plans to sell stake in biological engineering firm to Sansure Biotech Inc. (SHSE:688289).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.58 CNY | +0.11% |
|
-4.04% | -10.08% |
06-12 | Sansure Biotech's Tuberculosis Diagnostic Kit Gets EU Certification | MT |
04-26 | Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.08% | 1.39B | |
-11.78% | 11.24B | |
-13.76% | 7.29B | |
+29.50% | 5.57B | |
-0.19% | 5.31B | |
-19.19% | 3.68B | |
+7.62% | 2.58B | |
-65.24% | 2.33B | |
-10.48% | 2.23B | |
+27.80% | 2.21B |
- Stock Market
- Equities
- 688289 Stock
- News Sansure Biotech Inc.
- Gree Real Estate's Unit Scraps Plans to Sell Stake in Biological Engineering Firm